NanoOmics Lab
The NanoOmics Lab is dedicated to generating and disseminating fundamental knowledge at the intersection of nanotechnology, omics sciences, and blood biomarker discovery. We aim to develop nanotechnology tools to enhance early disease detection and personalise medicine, with a particular focus on neurodegeneration and neurooncology.
Recent Publications
British Journal of Cancer
A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer
C. Guerrero Quiles, H. Abumanhal-Masarweh, J. G. Abalos, T. Lodhi, D. Sanchez-Martinez, K. Reeves, Nicholas D. James, Emma Hall, Robert A. Huddart, Nuria Porta, P. Hoskin, L. V. Biolatti, M. Hadjidemetriou, C. M. West & A. Choudhury
Cell Reports Medicine
Combined multi-omics and multi-spectral profiling of plasma extracellular vesicles reveals liquid biopsy biomarkers for glioma diagnosis
Stephen David Robinson, Biniam Tsegay Haile, Matthew Reily-Bell, Olivia Iwanowytsch, Siobhan Palmer, Dorte Schou Nørøxe, Panagiota S. Filippou, Joanna Renaut, Alan Lazarus, Georgios Antoniou, Mark Samuels, Viviana Vella, Chrysa Filippopoulou, William Jones, Josephine Jung, Xiaoou Li, Nan Ji, Yang Zhang, Aleena Azam, Jane Skjoeth-Rasmussen, Ulrik Lassen, Adriana Saraiva, Ahmad Taha, Tania Slatter, Greg Jones, Rajesh Katare, Holly J. Butler, Matthew J. Baker, Marilena Hadjidemetriou, Duncan Gilbert, Benjamin Towler, Keyoumars Ashkan, Giles Critchley, Frances M.G. Pearl, and Georgios Giamas.
Communications Medicine
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity
Hanan Abumanhal-Masarweh, Salam A. Assi, Xinming Liu, Conrado Guerrero Quiles, Taha Lodhi, Kaye J. Williams, Eleanor J. Cheadle, Kostas Kostarelos, Ananya Choudhury, David C. Wedge, Catharine M. L. West & Marilena Hadjidemetriou
